Honjo, Japan

Noritoshi Koyama

This inventor holds 1 USPTO granted patent. Top assignee: Asta Medica, Aktiengesellschaft. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noritoshi Koyama. Retrieved from https://idiyas.com/inventor/noritoshi-koyama-1bra2sl7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noritoshi Koyama: Innovator in Pharmaceutical Composition

Introduction

Noritoshi Koyama is a notable inventor based in Honjo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable preparations containing azelastine hydrochloride. His work has implications for enhancing the stability and absorbability of pharmaceutical compositions.

Latest Patents

Koyama holds a patent for "Methods employing stable preparation containing azelastine hydrochloride." This innovative patent focuses on combining azelastine hydrochloride with certain fatty acids to improve the overall effectiveness of the composition. His patent portfolio includes 1 patent that showcases his expertise in this area.

Career Highlights

Koyama is associated with Asta Medica, Aktiengesellschaft, where he has contributed to various research and development projects. His work at Asta Medica has allowed him to explore new avenues in pharmaceutical formulations, leading to advancements in drug delivery systems.

Collaborations

Throughout his career, Koyama has collaborated with esteemed colleagues such as Yutaka Morita and Shigemitsu Ohsawa. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Noritoshi Koyama's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His work continues to influence the development of effective drug formulations, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…